Fogler W E
Biologics Evaluation Section, National Cancer Institute, Bethesda, Maryland 20892.
Biotechnol Ther. 1989;1(1):69-83.
The clinical potential and the limitations of synthetic muramyl peptides have been suggested through extensive work describing their immunomodulating properties and toxicology. The intent of this paper is to offer the clinician a summary of these studies and to introduce the reader to the biological effects associated with administration of muramyl peptides.
通过大量描述合成胞壁酰肽免疫调节特性和毒理学的研究，其临床潜力和局限性已得到揭示。本文旨在为临床医生总结这些研究，并向读者介绍与胞壁酰肽给药相关的生物学效应。
